The mean does not mean as much anymore: finding sub-groups for tailored therapeutics

Area of Science:

• Genomic medicine
• Clinical trial analysis
• Statistical modeling

Background:

• The genomics revolution is nascent, with ongoing efforts to translate biological insights into effective medicines.
• Understanding individual patient variability in drug response is crucial for public health.
• Clinical markers and socio-environmental factors influence treatment efficacy.

Purpose of the Study:

• To explore statistical complexities in clinical trial analysis for deeper insights.
• To demonstrate novel statistical methods for identifying patient subgroups with varied treatment responses.
• To showcase subgroup identification using statistical approaches.

Main Methods:

• Recursive partitioning methods were employed to identify predictor variables and their cut-off values.
• These methods defined patient subgroups exhibiting differential treatment responses.
• Validation was performed using independent clinical trial data.

Main Results:

• A classification tree, using baseline measures, identified patient subgroups with significantly better responses.
• Another classification tree, based on early treatment response, predicted long-term responders and non-responders.
• Potential for over-fitting and the need for validation were noted limitations.

Conclusions:

• Classification trees proved highly effective in identifying patient subgroups with exceptional treatment responses.
• The method is user-friendly, allowing for straightforward interpretation and implementation by clinicians.
• This approach facilitates personalized treatment strategies for individual patients.